| Issue Date | Title | Author(s) |
| 2021-04-13 | Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype. | Valdés-Mora, F; Salomon, R; Gloss, BS; Law, AMK; Venhuizen, J; Castillo, L; Murphy, KJ; Magenau, A; Papanicolaou, M; Rodriguez de la Fuente, L; Roden, DL; Colino-Sanguino, Y; Kikhtyak, Z; Farbehi, N; Conway, JRW; Sikta, N; Oakes, SR; Cox, TR; O'Donoghue, SI; Timpson, P; Ormandy, CJ; Gallego-Ortega, D |
| 2022-04-01 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | Araujo, AM; Abaurrea, A; Azcoaga, P; López-Velazco, JI; Manzano, S; Rodriguez, J; Rezola, R; Egia-Mendikute, L; Valdés-Mora, F; Flores, JM; Jenkins, L; Pulido, L; Osorio-Querejeta, I; Fernández-Nogueira, P; Ferrari, N; Viera, C; Martín-Martín, N; Tzankov, A; Eppenberger-Castori, S; Alvarez-Lopez, I; Urruticoechea, A; Bragado, P; Coleman, N; Palazón, A; Carracedo, A; Gallego-Ortega, D; Calvo, F; Isacke, CM; Caffarel, MM; Lawrie, CH |
| 2013-04 | Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. | Lee, HJ; Gallego-Ortega, D; Ledger, A; Schramek, D; Joshi, P; Szwarc, MM; Cho, C; Lydon, JP; Khokha, R; Penninger, JM; Ormandy, CJ |
| 2013-05-23 | Functional characterization of cancer-associated Gab1 mutations. | Ortiz-Padilla, C; Gallego-Ortega, D; Browne, BC; Hochgräfe, F; Caldon, CE; Lyons, RJ; Croucher, DR; Rickwood, D; Ormandy, CJ; Brummer, T; Daly, RJ |
| 2022-09-15 | Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing. | Johansen, MD; Mahbub, RM; Idrees, S; Nguyen, DH; Miemczyk, S; Pathinayake, P; Nichol, K; Hansbro, NG; Gearing, LJ; Hertzog, PJ; Gallego-Ortega, D; Britton, WJ; Saunders, BM; Wark, PA; Faiz, A; Hansbro, PM |
| 2013-11 | ELF5, normal mammary development and the heterogeneous phenotypes of breast cancer | Gallego-Ortega, D; Oakes, SR; Lee, HJ; Piggin, CL; Ormandy, CJ |
| 2022-10-03 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | Araujo, AM; Abaurrea, A; Azcoaga, P; López-Velazco, JI; Manzano, S; Rodriguez, J; Rezola, R; Egia-Mendikute, L; Valdés-Mora, F; Flores, JM; Jenkins, L; Pulido, L; Osorio-Querejeta, I; Fernández-Nogueira, P; Ferrari, N; Viera, C; Martín-Martín, N; Tzankov, A; Eppenberger-Castori, S; Alvarez-Lopez, I; Urruticoechea, A; Bragado, P; Coleman, N; Palazón, A; Carracedo, A; Gallego-Ortega, D; Calvo, F; Isacke, CM; Caffarel, MM; Lawrie, CH |
| 2023-03-01 | Rapid metabolomic screening of cancer cells via high-throughput static droplet microfluidics. | Radfar, P; Ding, L; de la Fuente, LR; Aboulkheyr, H; Gallego-Ortega, D; Warkiani, ME |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
| 2011-10 | Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. | Lee, HJ; Hinshelwood, RA; Bouras, T; Gallego-Ortega, D; Valdés-Mora, F; Blazek, K; Visvader, JE; Clark, SJ; Ormandy, CJ |
